Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, especially now that the Pharmalot campus has quieted down. Our shortest person has departed for the local schoolhouse, the other short one has left for the cubicle of the gainfully employed, and our surviving official mascot is happily snoozing nearby. As for us, we are brewing cups of stimulation — we are still hung up on pecan pie, for those who care — and foraging for items of interest. Speaking of which, here are a few. Hope your day goes well and you hit pay dirt …

Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drug maker contributed to the opioid crisis, Reuters reports. A bankruptcy filing would halt the lawsuits and allow Purdue to negotiate legal claims with plaintiffs under the supervision of a U.S. bankruptcy judge. Such a move would show how Purdue and its wealthy owners, the Sackler family, are under pressure to respond to litigation accusing the company of misleading doctors and patients about risks associated with prolonged use of its prescription opioids.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!